Investor | Duggan Robert W |
13D/G Filings
This page shows a list of all the recent 13D/G filings made by Duggan Robert W . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).
When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.
Date | Form | Target | Prev Shares |
Current Shares |
Change (Percent) |
Ownership (Percent) |
Change (Percent) |
|
---|---|---|---|---|---|---|---|---|
2024-12-19 |
|
PLSE / Pulse Biosciences, Inc. | 48,623,225 | 48,792,335 | ||||
2024-09-13 |
|
SMMT / Summit Therapeutics Inc. | 175,864,281 | 555,736,060 | ||||
2024-07-08 |
|
PLSE / Pulse Biosciences, Inc. | 37,975,319 | 48,623,225 | ||||
2023-12-15 |
|
PLSE / Pulse Biosciences, Inc. | 37,454,260 | 37,975,319 | ||||
2023-12-04 |
|
PLSE / Pulse Biosciences, Inc. | 36,904,880 | 37,454,260 | ||||
2023-05-11 |
|
PLSE / Pulse Biosciences, Inc. | 26,754,809 | 36,904,880 | ||||
2023-02-16 |
|
SMMT / Summit Therapeutics Inc. | 175,864,281 | 175,864,281 | ||||
2022-12-09 |
|
SMMT / Summit Therapeutics Inc. | 166,517,847 | 175,864,281 | ||||
2022-08-18 |
|
SMMT / Summit Therapeutics Inc. | 71,647,509 | 166,517,847 | ||||
2022-06-13 |
|
PLSE / Pulse Biosciences, Inc. | 15,196,495 | 26,754,809 | ||||
2021-07-02 |
|
PLSE / Pulse Biosciences, Inc. | 12,142,715 | 15,196,495 | ||||
2021-05-14 |
|
SUMM / SUMMIT THERAPEUTICS PLC | 60,281,588 | 71,647,509 | ||||
2021-05-11 |
|
PLSE / Pulse Biosciences, Inc. | 12,100,284 | 12,142,715 | ||||
2021-04-22 |
|
SUMM / SUMMIT THERAPEUTICS PLC | 60,281,588 | 60,281,588 | ||||
2021-03-26 |
|
SUMM / SUMMIT THERAPEUTICS PLC | 60,281,588 | |||||
2020-11-10 |
|
SMMT / Summit Therapeutics Inc. | 55,940,271 | 60,281,588 | ||||
2020-10-07 |
|
SMMT / Summit Therapeutics Inc. | 55,940,271 | 55,940,271 | ||||
2020-10-06 |
|
SMMT / Summit Therapeutics Inc. | 46,209,732 | 55,940,271 | ||||
2020-09-28 |
|
SMMT / Summit Therapeutics Inc. | 231,048,661 | 46,209,732 | ||||
2020-06-17 |
|
PLSE / Pulse Biosciences, Inc. | 9,080,731 | 12,100,284 | ||||
2020-01-16 |
|
SMMT / Summit Therapeutics Inc. | 269,368,810 | 231,048,661 | ||||
2019-12-27 |
|
SMMT / Summit Therapeutics Inc. | 78,288,205 | 269,368,810 | ||||
2019-12-10 |
|
SMMT / Summit Therapeutics Inc. | 78,288,205 | 78,288,205 | ||||
2019-04-12 |
|
/ Achaogen Inc | 3,384,153 | 2,982,453 | ||||
2019-04-05 |
|
/ Achaogen Inc | 4,320,551 | 3,384,153 | ||||
2019-03-28 |
|
/ Achaogen Inc | 5,757,839 | 4,320,551 | ||||
2019-03-20 |
|
/ Achaogen Inc | 7,035,727 | 5,757,839 | ||||
2019-03-13 |
|
/ Achaogen Inc | 9,389,734 | 7,035,727 | ||||
2019-02-26 |
|
/ Achaogen Inc | 9,389,734 | 9,389,734 | ||||
2019-01-22 |
|
SMMT / Summit Therapeutics Inc. | 78,288,205 | |||||
2019-01-18 |
|
AUPH / Aurinia Pharmaceuticals Inc. | 4,912,284 | 4,245,365 | ||||
2018-12-17 |
|
PLSE / Pulse Biosciences, Inc. | 5,832,612 | 9,080,731 | ||||
2018-12-12 |
|
/ Achaogen Inc | 8,230,052 | 9,389,734 | ||||
2018-05-07 |
|
/ Achaogen Inc | 7,023,076 | 8,230,052 | ||||
2018-04-24 |
|
/ Achaogen Inc | 7,023,076 | 7,023,076 | ||||
2018-04-23 |
|
/ Achaogen Inc | 6,347,318 | 7,023,076 | ||||
2018-03-14 |
|
/ Achaogen Inc | 6,347,318 | 6,347,318 | ||||
2018-03-13 |
|
/ Achaogen Inc | 5,579,910 | 6,347,318 | ||||
2017-12-11 |
|
/ Achaogen Inc | 5,579,910 | 5,579,910 | ||||
2017-12-09 |
|
/ Achaogen Inc | 3,074,717 | 5,579,910 | ||||
2017-10-23 |
|
AUPH / Aurinia Pharmaceuticals Inc. | 5,766,887 | 4,912,284 | ||||
2017-10-20 |
|
/ Achaogen Inc | 2,035,888 | 3,074,717 | ||||
2017-09-26 |
|
PLSE / Pulse Biosciences, Inc. | 3,832,612 | 5,832,612 | ||||
2017-09-18 |
|
PLSE / Pulse Biosciences, Inc. | 3,422,694 | 3,832,612 | ||||
2017-08-03 |
|
PLSE / Pulse Biosciences, Inc. | 3,061,316 | 3,422,694 | ||||
2017-05-12 |
|
PLSE / Pulse Biosciences, Inc. | 2,898,192 | 3,061,316 | ||||
2017-05-01 |
|
AUPH / Aurinia Pharmaceuticals Inc. | 5,766,887 | |||||
2017-04-20 |
|
PLSE / Pulse Biosciences, Inc. | 2,578,950 | 2,898,192 | ||||
2017-04-11 |
|
PLSE / Pulse Biosciences, Inc. | 2,173,359 | 2,578,950 | ||||
2017-03-28 |
|
/ Achaogen Inc | 2,035,888 | |||||
2017-02-21 |
|
PLSE / Pulse Biosciences, Inc. | 2,173,359 | |||||
2015-06-01 |
|
PCYC / Pharmacyclics | 13,553,330 | 0 | ||||
2015-03-09 |
|
PCYC / Pharmacyclics | 13,553,330 |